Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01218399 · ClinicalTrials.gov registry record · NA
Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01218399: Completed NA study, sponsored by Stanford University.
NCT01218399 is a NA study that has completed, run by Stanford University. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01218399, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with Stanford staff. We hypothesize that the budesonide/formoterol combination improves the efficacy of budesonide alone.
Interventions
- DRUG Symbicort
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2009-09 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01218399
The ClinicalTrials.gov registry entry for NCT01218399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Symbicort is the first listed.
NCT01218399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01218399 about?
NCT01218399 is a clinical study titled "Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations". This is an investigator-initiated study in which Dr. Nadeau wrote the protocol and received funding from an Astra Zeneca grant to direct, perform, and monitor the study on her own with Stanford staff. We hypothesize that the budesonide/formoterol combination improves the efficacy of budesonide alone...
What is the current status of trial NCT01218399?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2009-09. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01218399?
The interventions under investigation include: Symbicort (DRUG).
Who is sponsoring clinical trial NCT01218399?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.